Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder

SIMPLE SUMMARY: Bladder cancer is an aggressive disease and after operation many patients are at risk of recurrence and shortened survival. Specific proteins are known to be of importance in the development of cancers. One of these proteins is the urokinase-type plasminogen activator receptor (uPAR)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Dohn, Line H., Thind, Peter, Salling, Lisbeth, Lindberg, Henriette, Oersted, Sofie, Christensen, Ib J., Laerum, Ole D., Illemann, Martin, von der Maase, Hans, Høyer-Hansen, Gunilla, Pappot, Helle
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8156453/
https://ncbi.nlm.nih.gov/pubmed/34069121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102377
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы